Overview

Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions

Status:
Completed
Trial end date:
2023-12-20
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetic Characteristics of two formulations of Jaktinib Hydrochloride Tablets in Healthy Adult Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd